查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538524

全EXOME定序市场报告：2030 年趋势、预测与竞争分析

Whole Exome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全EXOME定序趋势与预测

预计到 2030 年，全球全EXOME定序市场将达到 37 亿美元，2024 年至 2030 年复合年增长率为 14.6%。该市场的主要驱动因素是定序在科学技术中的应用不断扩大、基因组和下一代定序技术的持续开拓以及对个人化医疗不断增长的需求。全球全EXOME定序市场前景广阔，临床诊断、药物发现和开发以及个人化医疗市场充满机会。

按片段进行全EXOME定序

这项研究包括按产品、技术、应用、最终用途和地区对全球全EXOME序的预测。

全EXOME定序市场洞察

Lucintel 预测，消耗品将在预测期内达到最高成长。

在该市场中，药物发现和市场开拓在预测期内仍将是最大的部分。

在预测期内，北美仍将是最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球全EXOME定序市场预计将达到 37 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球全EXOME定序市场预期复合年增长率为14.6%。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是这种测序在科学技术中的不断扩大的应用、基因组和次世代定序技术的持续开拓以及对个性化医疗不断增长的需求。

Q4.市场的主要细分市场是：

A4. 由于临床诊断、药物发现/开发和个人化医疗市场的机会，整个EXOME定序市场的未来性充满希望。

Q5.市场的主要企业是：

A5. 主要的全EXOME定序公司是：

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • BGI
  • PacBio
  • Oxford Nanopore Technologies
  • Azenta
  • CD Genomics
  • Novogene
  • Eurofins Genomics

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计消耗品在预测期间内将出现最高成长。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 在预测期内，北美仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球全EXOME定序市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球全EXOME定序市场趋势（2018-2023）与预测（2024-2030）
  • 按产品分類的全球EXOME定序市场
    • 装置
    • 消耗品
    • 服务
  • 按技术分類的全球EXOME定序市场
    • 合成定定序
    • ION半导体定序
    • 其他的
  • 全球EXOME定序市场（按应用）
    • 临床诊断
    • 药物发现与开发
    • 个人化医疗
    • 其他的
  • 按最终用途分類的全球EXOME定序市场
    • 学术研究所
    • 医院/诊所
    • 製药和生物技术公司
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球全EXOME定序市场（按地区）
  • 北美全EXOME定序市场
  • 欧洲全EXOME定序市场
  • 亚太全EXOME定序市场
  • 其他区域全EXOME定序市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球全EXOME定序市场成长机会（按产品）
    • 全球全EXOME定序市场成长机会（依技术）
    • 全球全EXOME定序市场成长机会（按应用）
    • 全球全EXOME定序市场成长机会（依最终用途）
    • 按地区分類的全球全EXOME定序市场成长机会
  • 全球全EXOME定序市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球全EXOME定序市场的产能
    • 全球全EXOME定序市场的併购与合资
    • 认证和许可

第七章主要企业概况

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • BGI
  • PacBio
  • Oxford Nanopore Technologies
  • Azenta
  • CD Genomics
  • Novogene
  • Eurofins Genomics
简介目录

Whole Exome Sequencing Trends and Forecast

The future of the global whole exome sequencing market looks promising with opportunities in the clinical diagnostic, drug discovery & development, and personalized medicine markets. The global whole exome sequencing market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are growing application of this sequencing in science and technology, ongoing development in genomics and next-generation sequencing technologies, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Whole Exome Sequencing by Segment

The study includes a forecast for the global whole exome sequencing by product, technology, application, end use, and region.

Whole Exome Sequencing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Whole Exome Sequencing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Sequencing by Synthesis
  • ION Semiconductor Sequencing
  • Others

Whole Exome Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Personalized Medicines
  • Others

Whole Exome Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academic & Research Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

Whole Exome Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Whole Exome Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies whole exome sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the whole exome sequencing companies profiled in this report include-

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • BGI
  • PacBio
  • Oxford Nanopore Technologies
  • Azenta
  • CD Genomics
  • Novogene
  • Eurofins Genomics

Whole Exome Sequencing Market Insights

Lucintel forecasts that consumable is expected to witness the highest growth over the forecast period.

Within this market, drug discovery & development will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Whole Exome Sequencing Market

Market Size Estimates: Whole exome sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Whole exome sequencing market size by various segments, such as by product, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Whole exome sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, applications, end uses, and regions for the whole exome sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the whole exome sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the whole exome sequencing market size?

Answer: The global whole exome sequencing market is expected to reach an estimated $3.7 billion by 2030.

Q2. What is the growth forecast for whole exome sequencing market?

Answer: The global whole exome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the whole exome sequencing market?

Answer: The major drivers for this market are growing application of this sequencing in science and technology, ongoing development in genomics and next-generation sequencing technologies, and rising demand for personalized medicine.

Q4. What are the major segments for whole exome sequencing market?

Answer: The future of the whole exome sequencing market looks promising with opportunities in the clinical diagnostic, drug discovery & development, and personalized medicine markets.

Q5. Who are the key whole exome sequencing market companies?

Answer: Some of the key whole exome sequencing companies are as follows:

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • BGI
  • PacBio
  • Oxford Nanopore Technologies
  • Azenta
  • CD Genomics
  • Novogene
  • Eurofins Genomics

Q6. Which whole exome sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that consumable is expected to witness the highest growth over the forecast period.

Q7. In whole exome sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the whole exome sequencing market by product (instruments, consumables, and services), technology (sequencing by synthesis, ion semiconductor sequencing, and others), application (clinical diagnostics, drug discovery & development, personalized medicines, and others), end use (academic & research institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Whole Exome Sequencing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Whole Exome Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Whole Exome Sequencing Market by Product
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Services
  • 3.4: Global Whole Exome Sequencing Market by Technology
    • 3.4.1: Sequencing by Synthesis
    • 3.4.2: ION Semiconductor Sequencing
    • 3.4.3: Others
  • 3.5: Global Whole Exome Sequencing Market by Application
    • 3.5.1: Clinical Diagnostics
    • 3.5.2: Drug Discovery & Development
    • 3.5.3: Personalized Medicines
    • 3.5.4: Others
  • 3.6: Global Whole Exome Sequencing Market by End Use
    • 3.6.1: Academic & Research Institutes
    • 3.6.2: Hospitals & Clinics
    • 3.6.3: Pharmaceutical & Biotechnology Companies
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Whole Exome Sequencing Market by Region
  • 4.2: North American Whole Exome Sequencing Market
    • 4.2.1: North American Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
    • 4.2.2: North American Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
  • 4.3: European Whole Exome Sequencing Market
    • 4.3.1: European Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
    • 4.3.2: European Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
  • 4.4: APAC Whole Exome Sequencing Market
    • 4.4.1: APAC Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
    • 4.4.2: APAC Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
  • 4.5: ROW Whole Exome Sequencing Market
    • 4.5.1: ROW Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
    • 4.5.2: ROW Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Whole Exome Sequencing Market by Product
    • 6.1.2: Growth Opportunities for the Global Whole Exome Sequencing Market by Technology
    • 6.1.3: Growth Opportunities for the Global Whole Exome Sequencing Market by Application
    • 6.1.4: Growth Opportunities for the Global Whole Exome Sequencing Market by End Use
    • 6.1.5: Growth Opportunities for the Global Whole Exome Sequencing Market by Region
  • 6.2: Emerging Trends in the Global Whole Exome Sequencing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Whole Exome Sequencing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Whole Exome Sequencing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Illumina
  • 7.3: Agilent Technologies
  • 7.4: BGI
  • 7.5: PacBio
  • 7.6: Oxford Nanopore Technologies
  • 7.7: Azenta
  • 7.8: CD Genomics
  • 7.9: Novogene
  • 7.10: Eurofins Genomics